Gynecology/Obstetrics CME

Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Expert Views on the Evolving Role of PARP Inhibitors in the Treatment of Ovarian Cancer
Bradley J. Monk, MD, FACS, FACOG
30 April, 2020
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
Peter Schmid, FRCP, MD, PhD
30 December, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine
Advances in Precision Care in Solid Tumor Oncology: Defining the Role of PARP Inhibitors
Robert Coleman, MD
8 November, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Advances in Medical Options for Uterine Fibroids and Endometriosis: Clinical Highlights From Montreal
Elizabeth A. Stewart, MD
25 June, 2019